Advertisement

Topics

Syngenta gains access to CRISPR-Cas9

04:55 EST 8 Nov 2017 | SmartBrief

The Broad Institute of MIT and Harvard granted Syngenta a nonexclusive license to CRISPR-Cas9 technology for agricultural app -More

Original Article: Syngenta gains access to CRISPR-Cas9

NEXT ARTICLE

More From BioPortfolio on "Syngenta gains access to CRISPR-Cas9"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...